rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1998-2-11
|
pubmed:abstractText |
Studies using tacrolimus and corticosteroids or the combination of cyclosporine, mycophenolate mofetil, and corticosteroids have been shown to reduce the incidence of biopsy-proven acute rejection episodes in cadaveric kidney recipients compared with cyclosporine-based immunosuppression. The current study is a retrospective analysis of our experience with tacrolimus combined with mycophenolate mofetil and steroids as primary immunosuppression for kidney transplant recipients.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
248-52
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9458023-Actuarial Analysis,
pubmed-meshheading:9458023-Adult,
pubmed-meshheading:9458023-Drug Therapy, Combination,
pubmed-meshheading:9458023-Female,
pubmed-meshheading:9458023-Glucocorticoids,
pubmed-meshheading:9458023-Graft Survival,
pubmed-meshheading:9458023-Humans,
pubmed-meshheading:9458023-Immunosuppression,
pubmed-meshheading:9458023-Immunosuppressive Agents,
pubmed-meshheading:9458023-Kidney Transplantation,
pubmed-meshheading:9458023-Male,
pubmed-meshheading:9458023-Middle Aged,
pubmed-meshheading:9458023-Mycophenolic Acid,
pubmed-meshheading:9458023-Retrospective Studies,
pubmed-meshheading:9458023-Tacrolimus,
pubmed-meshheading:9458023-Transplantation, Homologous
|
pubmed:year |
1998
|
pubmed:articleTitle |
Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients.
|
pubmed:affiliation |
Department of Medicine, University of Miami School of Medicine and Miami Veterans Administration Hospital, Florida 33101, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|